𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined Therapy with Interferon and Ribavirin in Chronic Hepatitis C Does Not Affect Serum Quasispecies Diversity

✍ Scribed by Silvia Sookoian; Gustavo Castaño; Bernardo Frider; Jerónimo Cello; Rodolfo Campos; Diego Flichman

Book ID
110294657
Publisher
Springer US
Year
2001
Tongue
English
Weight
58 KB
Volume
46
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Limitation of combination therapy of int
Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C
✍ Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to clarify the effect of patient age on the efficacy a